Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models.

Anaclet C, Parmentier R, Ouk K, Guidon G, Buda C, Sastre JP, Akaoka H, Sergeeva OA, Yanagisawa M, Ohtsu H, Franco P, Haas HL, Lin JS.

J Neurosci. 2009 Nov 18;29(46):14423-38. doi: 10.1523/JNEUROSCI.2604-09.2009.

2.

Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptor.

Malherbe P, Borroni E, Gobbi L, Knust H, Nettekoven M, Pinard E, Roche O, Rogers-Evans M, Wettstein JG, Moreau JL.

Br J Pharmacol. 2009 Apr;156(8):1326-41. doi: 10.1111/j.1476-5381.2009.00127.x.

3.

Sleep homeostasis modulates hypocretin-mediated sleep-to-wake transitions.

Carter ME, Adamantidis A, Ohtsu H, Deisseroth K, de Lecea L.

J Neurosci. 2009 Sep 2;29(35):10939-49. doi: 10.1523/JNEUROSCI.1205-09.2009.

4.

Histamine-1 receptor is not required as a downstream effector of orexin-2 receptor in maintenance of basal sleep/wake states.

Hondo M, Nagai K, Ohno K, Kisanuki Y, Willie JT, Watanabe T, Yanagisawa M, Sakurai T.

Acta Physiol (Oxf). 2010 Mar;198(3):287-94. doi: 10.1111/j.1748-1716.2009.02032.x. Epub 2009 Aug 20.

5.

Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat.

Dugovic C, Shelton JE, Aluisio LE, Fraser IC, Jiang X, Sutton SW, Bonaventure P, Yun S, Li X, Lord B, Dvorak CA, Carruthers NI, Lovenberg TW.

J Pharmacol Exp Ther. 2009 Jul;330(1):142-51. doi: 10.1124/jpet.109.152009. Epub 2009 Apr 10.

6.

Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls.

Nishino S, Sakurai E, Nevsimalova S, Yoshida Y, Watanabe T, Yanai K, Mignot E.

Sleep. 2009 Feb;32(2):175-80.

7.

A consensus definition of cataplexy in mouse models of narcolepsy.

Scammell TE, Willie JT, Guilleminault C, Siegel JM; International Working Group on Rodent Models of Narcolepsy.

Sleep. 2009 Jan;32(1):111-6.

8.

EP3 prostaglandin receptors in the median preoptic nucleus are critical for fever responses.

Lazarus M, Yoshida K, Coppari R, Bass CE, Mochizuki T, Lowell BB, Saper CB.

Nat Neurosci. 2007 Sep;10(9):1131-3. Epub 2007 Aug 5.

PMID:
17676060
9.

Narcolepsy with cataplexy.

Dauvilliers Y, Arnulf I, Mignot E.

Lancet. 2007 Feb 10;369(9560):499-511. Review.

PMID:
17292770
10.

Afferents to the orexin neurons of the rat brain.

Yoshida K, McCormack S, EspaƱa RA, Crocker A, Scammell TE.

J Comp Neurol. 2006 Feb 10;494(5):845-61.

11.

Mice lacking ghrelin receptors resist the development of diet-induced obesity.

Zigman JM, Nakano Y, Coppari R, Balthasar N, Marcus JN, Lee CE, Jones JE, Deysher AE, Waxman AR, White RD, Williams TD, Lachey JL, Seeley RJ, Lowell BB, Elmquist JK.

J Clin Invest. 2005 Dec;115(12):3564-72.

12.

Divergence of melanocortin pathways in the control of food intake and energy expenditure.

Balthasar N, Dalgaard LT, Lee CE, Yu J, Funahashi H, Williams T, Ferreira M, Tang V, McGovern RA, Kenny CD, Christiansen LM, Edelstein E, Choi B, Boss O, Aschkenasi C, Zhang CY, Mountjoy K, Kishi T, Elmquist JK, Lowell BB.

Cell. 2005 Nov 4;123(3):493-505.

13.

Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle.

Lee MG, Hassani OK, Jones BE.

J Neurosci. 2005 Jul 13;25(28):6716-20.

14.

Behavioral correlates of activity in identified hypocretin/orexin neurons.

Mileykovskiy BY, Kiyashchenko LI, Siegel JM.

Neuron. 2005 Jun 2;46(5):787-98.

15.

Behavioral state instability in orexin knock-out mice.

Mochizuki T, Crocker A, McCormack S, Yanagisawa M, Sakurai T, Scammell TE.

J Neurosci. 2004 Jul 14;24(28):6291-300.

16.

Focal deletion of the adenosine A1 receptor in adult mice using an adeno-associated viral vector.

Scammell TE, Arrigoni E, Thompson MA, Ronan PJ, Saper CB, Greene RW.

J Neurosci. 2003 Jul 2;23(13):5762-70.

17.

Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes.

Willie JT, Chemelli RM, Sinton CM, Tokita S, Williams SC, Kisanuki YY, Marcus JN, Lee C, Elmquist JK, Kohlmeier KA, Leonard CS, Richardson JA, Hammer RE, Yanagisawa M.

Neuron. 2003 Jun 5;38(5):715-30.

18.
19.
20.

Orexins activate histaminergic neurons via the orexin 2 receptor.

Yamanaka A, Tsujino N, Funahashi H, Honda K, Guan JL, Wang QP, Tominaga M, Goto K, Shioda S, Sakurai T.

Biochem Biophys Res Commun. 2002 Feb 1;290(4):1237-45.

PMID:
11811995

Supplemental Content

Support Center